Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-18 2024-04-25 216466
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-08 2024-03-07 218983
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-07 2024-04-25 221546
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-18 2024-03-21 222572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-04-05 223856
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-04-25 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-05 2024-04-25 224445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-18 2024-04-18 225492
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-13 2020-02-13 1674
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-10 2017-09-19 9805
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-09-19 92151
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-11-21 92154
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT ESCITALOPRAM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99971
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99974

Showing 2621 to 2640 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250